Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-09
1987-07-14
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 83, 546 89, 546 80, 546 81, 544345, 544333, 514291, A61K 31495, A61K 31435, C07D49100, C07D45504
Patent
active
046802983
ABSTRACT:
Substituted quinoline, [1,5]- and [1,8]-naphthyridine and pyrido[2,3-b]pyrazine derivatives are anti-allergic, anti-inflammatory and cytoprotective agents. Methods for their preparation and use are disclosed.
REFERENCES:
patent: 4113731 (1978-09-01), Winters et al.
patent: 4232017 (1980-11-01), Winters et al.
patent: 4452800 (1984-06-01), Sherlock
Bulletin de la Societe Chimique de France, No. 1, 1968, pp. 364-369, Paris, FR; C. Fournier et al.
Chemical Abstracts, vol. 88, 1978, pp. 570-571, No. 105298y.
Journal of the Chemical Society, Perkin Transaction 1, Sep. 1983, pp. 2077-2087, London, GB; D. G. Hawkins et al.
Chemical Abstracts, vol. 101, No. 5, 30th Jul. 1984, p. 504, No. 38382t, E. M. Peresleni et al.
Japanese published patent 5-8-391 (abstract thereof).
Billups Richard C.
Jiles Henry R.
Miller Stephen I.
Nelson James R.
Schering Corporation
LandOfFree
Tricyclic anti-allergy and use as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic anti-allergy and use as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic anti-allergy and use as anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1427790